非酒精性脂肪肝
等位基因
基因敲除
单核苷酸多态性
脂肪肝
次等位基因频率
表型
基因
内科学
生物
基因型
遗传学
分子生物学
医学
疾病
作者
Justin K. Murray,Jason Long,Lei Liu,Shivani Singh,Danielle Pruitt,Michael M. Ollmann,Elissa Swearingen,Miki Hardy,Oliver Homann,Bin Wu,Jerry Ryan Holder,Kelvin Sham,Brad Herberich,Mei-Chu Lo,Hui Hannah Dou,Artem Shkumatov,Mónica Florio,Ingrid C. Rulifson
出处
期刊:Nucleic Acid Therapeutics
[Mary Ann Liebert]
日期:2021-10-01
卷期号:31 (5): 324-340
被引量:6
标识
DOI:10.1089/nat.2021.0026
摘要
Human genome wide association studies confirm the association of the rs738409 single nucleotide polymorphism (SNP) in the gene encoding protein patatin like phospholipase domain containing 3 (PNPLA3) with nonalcoholic fatty liver disease (NAFLD); the presence of the resulting mutant PNPLA3 I148M protein is a driver of nonalcoholic steatohepatitis (NASH). While Pnpla3-deficient mice do not display an adverse phenotype, the safety of knocking down endogenous wild type PNPLA3 in humans remains unknown. To expand the scope of a potential targeted NAFLD therapeutic to both homozygous and heterozygous PNPLA3 rs738409 populations, we sought to identify a minor allele-specific small interfering RNA (siRNA). Limiting our search to SNP-spanning triggers, a series of chemically modified siRNA were tested in vitro for activity and selectivity toward PNPLA3 rs738409 mRNA. Conjugation of the siRNA to a triantennary N-acetylgalactosamine (GalNAc) ligand enabled in vivo screening using adeno-associated virus to overexpress human PNPLA3I148M versus human PNPLA3I148I in mouse livers. Structure-activity relationship optimization yielded potent and minor allele-specific compounds that achieved high levels of mRNA and protein knockdown of human PNPLA3I148M but not PNPLA3I148I. Testing of the minor allele-specific siRNA in PNPLA3I148M-expressing mice fed a NASH-inducing diet prevented PNPLA3I148M-driven disease phenotypes, thus demonstrating the potential of a precision medicine approach to treating NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI